Has the BRCA Monopoly Been Reborn?

Has the BRCA Monopoly Been Reborn?

A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time – at >$4000 a pop – in order to qualify for a new drug called...
Genetic Privacy Part 2: The Case For

Genetic Privacy Part 2: The Case For

Last week in Genetic Privacy Part 1, we discussed the potential harm done when a patient chooses not to share her data with other family members. Such arguments, and the argument that widely sharing genetic data would advance scientific research, have made some...